Metabolic abnormalities and oxidative stress in lupus

Area of Science:

• Immunology
• Metabolic pathways
• Oxidative stress

Background:

• Immune cell metabolism is crucial for effective immune responses.
• Metabolic checkpoint failures in autoimmunity can cause immune cell hyperactivation and tissue damage.
• Oxidative stress exacerbates immune dysregulation and host injury in autoimmune diseases.

Purpose of the Study:

• To review immune cell metabolism signatures in systemic lupus erythematosus (SLE).
• To discuss the impact of heightened oxidative stress in SLE patients.
• To explore potential therapeutic strategies targeting metabolic imbalances and oxidative stress.

Main Methods:

• Review of recent insights into immune cell metabolism in SLE.
• Analysis of the role of oxidative stress and mitochondrial reactive oxygen species (ROS).
• Evaluation of therapeutic interventions in experimental lupus models.

Main Results:

• Inhibitors of glucose metabolism, mTOR pathway modulators, and PPAR-γ agonists show therapeutic benefits in lupus models.
• Mitochondrial ROS and oxidative stress-induced modifications are detrimental in lupus.
• Therapies targeting metabolic reconfiguration and reducing mitochondrial ROS are under investigation.

Conclusions:

• Knowledge gaps exist regarding the metabolic requirements of key SLE immune cells like myeloid and B cells.
• SLE-specific metabolic signatures have been identified.
• Targeting these signatures and mitochondrial ROS holds therapeutic potential for SLE patients.